| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
Roscovitine |
GDSC1000 |
pan-cancer |
AAC |
0.0072 |
0.9 |
| mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
-0.0061 |
0.9 |